Tim-1 blockade with RMT1-10 increases T regulatory cells and prolongs the survival of high-risk corneal allografts in mice

Exp Eye Res. 2014 May:122:86-93. doi: 10.1016/j.exer.2014.02.019. Epub 2014 Mar 5.

Abstract

Anti-Tim-1 monoclonal antibody (mAb) RMT1-10 is effective in promoting allograft survival through blocking Tim-1. However, its role in corneal transplantation is unclear. This study aims to evaluate the effect of RMT1-10 on high-risk corneal transplantation. BALB/c mice were transplanted with corneal grafts from C57BL/6 mice and intraperitoneally injected with RMT1-10 or isotype IgG. The transparency of corneal graft was evaluated by slit lamp biomicroscopy. Flow cytometry was used to determine the phenotype of CD4(+) T cells, including CD154, Tim-3, CD25 and Foxp3, and to analyze the proliferation capacity of CD4(+) T cells and the suppressive capacity of T regulatory (Treg) cells. The levels of interferon-gamma (IFN-γ), IL-4 and transforming growth factor-beta1 (TGF-β1) were investigated by intracellular staining and/or ELISA assay. The delayed-type hypersensitivity (DTH) response was evaluated by ear swelling assay. RMT1-10 therapy delayed the onset of rejection and significantly prolonged the survival of corneal allograft. In RMT1-10 treated mice, percentages of CD4(+)CD154(+) cells and CD4(+)Tim-3(+) cells were significantly decreased while the frequency of CD4(+)CD25(+)Foxp3(+) Treg cells was significantly up-regulated, compared with those of isotype IgG treated mice. And, in vitro proliferation of CD4(+) T cells was significantly inhibited by RMT1-10. In addition, percentage of intracellular expression of IFN-γ and IL-4 in CD4(+) T cells isolated from RMT1-10 treated mice was significantly reduced. After co-culturing with RMT1-10 in vitro, CD4(+) T cells produced significantly decreased levels of IFN-γ and IL-4 and significantly increased levels of TGF-β1. Furthermore, RMT1-10 inhibited DTH response of recipient mice and enhanced the suppressive capacity of Treg cells isolated from RMT1-10 treated mice. Our data indicate that Tim-1 blockade with RMT1-10 could suppress immunological rejection and prolong the survival of corneal allograft through regulating T cell responses.

Keywords: T regulatory cells; Tim-1; high-risk corneal allograft rejection; mice.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allografts
  • Animals
  • Antibodies, Blocking / pharmacology*
  • Antibodies, Monoclonal / pharmacology*
  • CD4-Positive T-Lymphocytes / physiology
  • CD40 Ligand / metabolism
  • Cell Proliferation
  • Enzyme-Linked Immunosorbent Assay
  • Flow Cytometry
  • Forkhead Transcription Factors / metabolism
  • Graft Survival / immunology*
  • Hepatitis A Virus Cellular Receptor 1
  • Hepatitis A Virus Cellular Receptor 2
  • Injections, Intraperitoneal
  • Interferon-gamma / metabolism
  • Interleukin-4 / metabolism
  • Keratoplasty, Penetrating*
  • Male
  • Membrane Proteins / antagonists & inhibitors*
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Receptors, Virus / metabolism
  • T-Lymphocytes, Regulatory / immunology*
  • Transforming Growth Factor beta1 / metabolism

Substances

  • Antibodies, Blocking
  • Antibodies, Monoclonal
  • Forkhead Transcription Factors
  • Foxp3 protein, mouse
  • Havcr1 protein, mouse
  • Havcr2 protein, mouse
  • Hepatitis A Virus Cellular Receptor 1
  • Hepatitis A Virus Cellular Receptor 2
  • Membrane Proteins
  • Receptors, Virus
  • Transforming Growth Factor beta1
  • CD40 Ligand
  • Interleukin-4
  • Interferon-gamma